SS-31 (also known as Elamipretide, Bendavia, and MTP-131) is the leading tetrapeptide in the Szeto-Schiller peptide family, with the sequence D-Arg-Dmt-Lys-Phe-NH₂ and a molecular weight of 639.8 Da. It is a positively charged aromatic cationic peptide. Unlike MOTS-c (discussed earlier) which uses retrograde signaling, and unlike Tirz/Retatrutide which acts as an incretin, it directly "drills" into the inner mitochondrial membrane to repair it-in the field, it's called "mitochondrial glue" or "cardiolipin bodyguard." It's currently the most advanced mitochondrial-targeting peptide in clinical trials (it received orphan drug status for Barth syndrome and underwent Phase II/III trials for heart failure and primary mitochondrial myopathy).
What exactly is it?
SS-31, scientifically known as Elamipretide, is a small peptide consisting of only four amino acids, with the sequence D-Arg-dimethylTyr-Lys-Phe-NH2, and a molecular weight of approximately 640. Despite its small size, it is very precisely designed-carrying three positive charges, it can be attracted to the mitochondrial membrane by its large negative potential, accumulating at a concentration approximately 5000 times higher within the mitochondria. This means that a very small dose can be used, but the drug concentration at the target site can be extremely high.
How does it work?
The core mechanism is simple: it binds to cardiolipin. Cardiolipin is a phospholipid unique to the inner mitochondrial membrane, and it is responsible for assembling the protein complexes of the electron transport chain into "supercomplexes" for efficient operation. Aging, ischemia, and oxidative stress can damage or oxidize cardiolipin, causing the electron transport chain to break down, ATP production to plummet, and a large amount of reactive oxygen species (ROS) to leak out, creating a vicious cycle.
Once inside, SS-31 acts like a scaffold, stabilizing cardiolipin and reorganizing the electron transport chain. With smoother electron flow, ROS naturally decreases, and ATP production recovers. Additionally, it inhibits the opening of the mitochondrial permeability transition pore (mPTP)-once this pore opens, mitochondria swell, membrane potential collapses, and ultimately, cytochrome c is released, triggering apoptosis. SS-31 holds this gate open, allowing cells to survive longer.
Another crucial point is that it has virtually no effect on normal mitochondria, only exerting its effects under damaged or stressed conditions. This selectivity makes it far less prone to side effects than many indiscriminate antioxidants.
Storage Conditions:
Lyophilized powder: Freeze at -20°C, protect from light, and seal tightly. It can be stored for several months without problems.
Reconstituted: Immediately refrigerate (2-8°C) and use within 4 weeks. Never refrozen the reconstituted solution, as freeze-thaw cycles will damage the peptide chain structure. Gently shake when dissolving; avoid vigorous agitation.
The rubber stopper on the vial is usually self-sealing; it will reseal itself after the injection and removal of the needle. However, aseptic technique should still be maintained as much as possible.
Precautions
Administration Method: Clinical studies primarily use subcutaneous injection. While oral administration allows for some absorption, bioavailability data is very limited. For optimal effectiveness, injection is the most reliable method. Injection site reactions are the most common side effects, including redness, itching, and induration, which usually resolve on their own.
Not a Panacea: While it does have promising clinical data on mitochondrial dysfunction-related fatigue, muscle atrophy, and cardiorenal protection, it doesn't cure every disease. Furthermore, some trial results are actually negative; don't be misled by marketing hype.
Half-Life: The elimination half-life in vivo is approximately 2 hours, so daily dosing is necessary clinically. Peak plasma concentration is reached in 15 minutes, and the mitochondrial steady state is around 30 minutes.
Source Issues: Currently, the FDA has only approved it for Barth syndrome (brand name Forzinity). Other indications are still under investigation. Many "research-grade" products on the market vary greatly in quality; if you're using them for personal use, you need to be extremely careful about their source and purity.
Regarding compatibility: Theoretically, SS-31 can complement NAD+ precursors and CoQ10-SS-31 repairs the machine, while NAD+/CoQ10 provides the raw materials. However, the specific combination is still undetermined; don't blindly pile on ingredients.
In general, SS-31 is one of the few truly "targeted" products in the field of mitochondrial intervention, not just a generalized antioxidant. However, peptides are more complicated to store and handle than small molecules, and they are not cheap. Before purchasing, it's best to carefully consider whether you actually need mitochondrial repair.
Hot Tags: pharmaceutical r&d peptide ss-31 cas: 736992-21-5, China pharmaceutical r&d peptide ss-31 cas: 736992-21-5 manufacturers, suppliers, factory
